February 2021: European Regulatory Update

TranspariMed published an article How will national regulators in Europe impose fines for missing clinical trial results?

In this article, TranspariMED’s legal analyst Muhammad Dwistaraifa Rasendriya explains the legal context and how the process will work. As a summary, even though national medicines regulators will get clear legal powers to impose fines and other sanctions on European companies and institutions that fail to make the results of their drug trials public, there will be variation in the amount/type/applicability of the penalty depending on what act/law is passed in each EU country.

Click here for the original article.

Leave a Reply